Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07224906 · ClinicalTrials.gov registry record
Observational Study of Patients Undergoing Diagnostic Right Heart Catheterization
A clinical trial of Pulmonary Hypertension and Valve Disease, Heart, sponsored by HemoCept.
- Recruiting
- Registry status
- 50
- Enrollment target
- 1
- Study location
NCT07224906 is a study of Pulmonary Hypertension and Valve Disease, Heart that is actively recruiting participants, run by HemoCept. The registered enrollment target is 50 participants, below the 613-participant average among 72 other Pulmonary Hypertension trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state.
The verdict
NCT07224906, a study of Pulmonary Hypertension and Valve Disease, Heart, is actively recruiting participants, sponsored by HemoCept.
- RECRUITING
- Registry status
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of this observational pilot study is to collect HemoCept device data from subjects undergoing diagnostic right heart catheterization (RHC) procedures.
Conditions Studied
Study Locations (1)
Colorado
- Boulder Heart - Boulder
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2025-12-01 |
| Est. Completion | 2026-03-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07224906
The ClinicalTrials.gov registry entry for NCT07224906 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 613-participant average among 72 other Pulmonary Hypertension trials with a reported enrollment target (92% lower). The listed sponsor is HemoCept, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Pulmonary Hypertension appearing as the primary indexed condition, and to 0 interventions.
NCT07224906 reports 1 study location spanning 1 distinct geographic area - top geographies include Colorado.
Frequently Asked Questions
What is clinical trial NCT07224906 about?
NCT07224906 is a clinical study titled "Observational Study of Patients Undergoing Diagnostic Right Heart Catheterization". The objective of this observational pilot study is to collect HemoCept device data from subjects undergoing diagnostic right heart catheterization (RHC) procedures.
What is the current status of trial NCT07224906?
This trial is currently recruiting. The enrollment target is 50 participants. The study started on 2025-12-01. Estimated completion is 2026-03-30.
What conditions does trial NCT07224906 study?
This clinical trial studies the following conditions: Pulmonary Hypertension, Valve Disease, Heart, Congestive Heart Failure(CHF).
Who is sponsoring clinical trial NCT07224906?
This trial is sponsored by HemoCept, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07224906 being conducted?
This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pulmonary Hypertension
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Pulmonary Hypertension Screening in Patients With Interstitial Lung Disease for Earlier Detection
RECRUITING
-
Development of an Algorithm to Detect Pulmonary Hypertension Using an Electronic Stethoscope
RECRUITING
-
Treatment of Pulmonary Arterial Hypertension Using the Aria CV Pulmonary Hypertension System
RECRUITING · NA
-
Heart Institute Biobank & Registry for Adult Congenital Heart Disease and Related Disorders
RECRUITING
-
LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF
RECRUITING · Phase 3
-
Hemodynamic Assessment of underLying myocyTe Function in Right Heart Failure
RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.